• Produktbild: Advances in Cardiomyopathies
  • Produktbild: Advances in Cardiomyopathies

Advances in Cardiomyopathies Proceedings of the II Florence Meeting on Advances on Cardiomyopathies April 24–26, 1997

Fr. 72.90

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

11.08.2012

Herausgeber

Fulvio Camerini + weitere

Verlag

Springer Italia

Seitenzahl

317

Maße (L/B/H)

24.4/17/1.9 cm

Gewicht

580 g

Auflage

Softcover reprint of the original 1st ed. 1998

Sprache

Englisch

ISBN

978-88--4702181-5

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

11.08.2012

Herausgeber

Verlag

Springer Italia

Seitenzahl

317

Maße (L/B/H)

24.4/17/1.9 cm

Gewicht

580 g

Auflage

Softcover reprint of the original 1st ed. 1998

Sprache

Englisch

ISBN

978-88--4702181-5

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Advances in Cardiomyopathies
  • Produktbild: Advances in Cardiomyopathies
  • Introduction: II Florence Meeting on Advances in Cardiomyopathies.- The Classification of Cardiomyopathies.- Hypertrophic Cardiomyopathy.- The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy.- The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I. Natural History and Clinical Course of Unselected Patients.- The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients.- Detection and Clinical Consequences of Myocardial Ischemia and Reduced Coronary Reserve.- Identification and Management of High Risk Patients with Hypertrophic Cardiomyopathy.- Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist’s View.- The Clinicopathologic Spectrum of Hypertrophic Cardiomiopathy. The Experience of the Italian Heart Transplant Program.- Medical Treatment Options in Hypertrophic Cardiomyopathy.- DDD Pacing in Hypertrophic Cardiomyopathy: State of the Art.- Indications and Outcome of Cardiac Surgery for Severely Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy.- Dilated Cardiomyopathy: Etiology, Pathophysiology and Clinical Data.- Genetic Basis of Dilated Cardiomyopathy.- Virus Infection in Cardiomyopathies: Brief Overview, Recent Advances.- Organ-Specific Cardiac Autoantibodies in Dilated Cardiomyopathy: Pathogenetic Implications.- Inflammatory Cardiomyopathy: Diagnostic and Therapeutical Options.- Mitochondrial DNA Mutations and Cardiomyopathies.- Pathophysiologic Role of Coronary Microcirculatory Impairment in Dilated Cardiomyopathy.- Myocardial Catecholamines and Inotropic Response in Heart Muscle Disease.- Molecular Biology of Heart Failure.- Dilated Cardiomyopathy: Does Etiological Heterogeneity Portend Clinical Heterogeneity?.- Recent Advances in Etiopathogenesis of Dilated Cardiomyopathy: Which Relevance for the Clinical Cardiologist?.- The Italian Multicentric Study: Natural History of Dilated Cardiomyopathy.- Mildly Dilated Cardiomyopathy.- Dilated Cardiomyopathy: Treatment.- Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis).- Prevention of Sudden Death in Patients with Dilated Cardiomyopathy.- Medical Treatment of Heart Failure: Problems in Dilated Cardiomyopathy.- Treatment of Dilated Cardiomyopathies with ?-adrenergic Blocking Agents.- The role of ?-Blockers in the Management of Heart Failure: Results of Controlled Trials.- Controversial Issues on ?-Blocker Treatment: Has Metoprolol an Additive Effect to Conventional Medical Treatment in Heart Failure Due to Dilated Cardiomyopathy?.- ?-Blockers for Heart Failure: Practical Issues.- DDD Pacing in Dilated Cardiomyopathy.- End-Stage Heart Failure and Timing of Heart Transplantation.- Cardiomyoplasty: Surgical Therapy for Ischemic and Idiopathic Dilated Cardiomyopathies.- Left Ventricular Assist Device as Bridge to Transplantation.